Community HIV Treatment Advocacy Programs May Support Treatment Adherence

Published in: AIDS Education and Prevention, v. 24, no. 1, Feb. 2012, p. 1-14

Posted on RAND.org on February 01, 2012

by Laura M. Bogart, Glenn Wagner, Matt G. Mutchler, Brian Risley, Bryce W McDavitt, Tara McKay, David J. Klein

Read More

Access further information on this document at AIDS Education and Prevention

This article was published outside of RAND. The full text of the article can be found at the link above.

Treatment advocacy (TA) programs, based in AIDS service organizations and clinics, aim to engage clients into care and support antiretroviral treatment (ART) adherence through client-centered counseling; advocate for patients with providers; and provide social service referrals. Systematic evaluations of TA are lacking. We conducted a non-randomized evaluation examining relationships of TA participation to adherence, care engagement, social services utilization, unmet needs, patient self-advocacy, and adherence self-efficacy among 121 HIV-positive clients (36 in TA, 85 not in TA; 87% male, 34% African American, 31% White, 19% Latino). In multivariate models, TA participants (vs. non-TA participants) showed higher electronically monitored [85.3% vs. 70.7% of doses taken; b(SE) = 13.16(5.55), p < .05] and self-reported [91.1% vs. 75.0%; b(SE) = 11.60(5.65), p < .05] adherence; utilized more social service programs [Ms = 5.2 vs. 3.4; b(SE) = 1.97(0.48), p < .0001]; and had fewer unmet social-service needs [Ms = 1.8 vs. 2.7; b(SE) = −1.06(0.48), p < .05]. Findings suggest the need for a randomized controlled trial of TA.

This report is part of the RAND Corporation external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.